Middle East Healthcare Company SJSC
SAU:4009

Watchlist Manager
Middle East Healthcare Company SJSC Logo
Middle East Healthcare Company SJSC
SAU:4009
Watchlist
Price: 68 SAR -1.45% Market Closed
Market Cap: 6.3B SAR
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
+23%
Revenue
Forecast
+10%
Operating Income
Forecast
+14%
Net Income
Forecast
+17%

Wall Street
Price Targets

Price Targets Summary
Middle East Healthcare Company SJSC

Wall Street analysts forecast Middle East Healthcare Company SJSC stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Middle East Healthcare Company SJSC is 85.2 SAR with a low forecast of 76.76 SAR and a high forecast of 96.6 SAR.

Lowest Forecast
Wall Street Target
76.76 SAR
13% Upside
Average Forecast
Wall Street Target
85.2 SAR
25% Upside
Highest Forecast
Wall Street Target
96.6 SAR
42% Upside
Lowest
Price Target
76.76 SAR
13% Upside
Average
Price Target
85.2 SAR
25% Upside
Highest
Price Target
96.6 SAR
42% Upside
Middle East Healthcare Company SJSC Competitors:
Price Targets
MAXHEALTH
Max Healthcare Institute Ltd
10% Upside
H
301267
Huaxia Eye Hospital Group Co Ltd
41% Upside
SIA
Sienna Senior Living Inc
14% Upside
V
VIBHA
Vibhavadi Medical Center PCL
39% Upside
MAXHEALTH
Max Healthcare Institute Ltd
10% Upside
H
301267
Huaxia Eye Hospital Group Co Ltd
41% Upside
SIA
Sienna Senior Living Inc
14% Upside
V
VIBHA
Vibhavadi Medical Center PCL
39% Upside
MPARK.E
MLP Saglik Hizmetleri AS
55% Upside
EXE
Extendicare Inc
4% Upside
P
PHG
Patrangsit Healthcare Group PCL
55% Upside

Revenue
Forecast

Revenue Estimate
Middle East Healthcare Company SJSC

For the last 8 years the compound annual growth rate for Middle East Healthcare Company SJSC's revenue is 8%. The projected CAGR for the next 3 years is 12%.

8%
Past Growth
12%
Estimated Growth
Estimates Accuracy
-3%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Middle East Healthcare Company SJSC

For the last 8 years the compound annual growth rate for Middle East Healthcare Company SJSC's operating income is 3%. The projected CAGR for the next 3 years is 10%.

3%
Past Growth
10%
Estimated Growth
Estimates Accuracy
-5%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Middle East Healthcare Company SJSC

For the last 8 years the compound annual growth rate for Middle East Healthcare Company SJSC's net income is -3%. The projected CAGR for the next 3 years is 14%.

-3%
Past Growth
14%
Estimated Growth
Estimates Accuracy
-7%
Average Miss
What are analyst estimates?

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Middle East Healthcare Company SJSC's stock price target?
Price Target
85.2 SAR

According to Wall Street analysts, the average 1-year price target for Middle East Healthcare Company SJSC is 85.2 SAR with a low forecast of 76.76 SAR and a high forecast of 96.6 SAR.

What is Middle East Healthcare Company SJSC's Revenue forecast?
Projected CAGR
12%

For the last 8 years the compound annual growth rate for Middle East Healthcare Company SJSC's revenue is 8%. The projected CAGR for the next 3 years is 12%.

What is Middle East Healthcare Company SJSC's Operating Income forecast?
Projected CAGR
10%

For the last 8 years the compound annual growth rate for Middle East Healthcare Company SJSC's operating income is 3%. The projected CAGR for the next 3 years is 10%.

What is Middle East Healthcare Company SJSC's Net Income forecast?
Projected CAGR
14%

For the last 8 years the compound annual growth rate for Middle East Healthcare Company SJSC's net income is -3%. The projected CAGR for the next 3 years is 14%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 248,700+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.